Subscribe
Tuesday, December 2, 2025
10 C
London
type here...
Subscribe

Tag: Antisense Therapeutics

Antisense Therapeutics: Starts dosing monkeys in ATL1102 toxicology study

FinTech Steve Sam -
Antisense Therapeutics Starts dosing monkeys in ATL1102 toxicology study Antisense Therapeutics (ANP) commences the dosing stage of a nine-month...

Antisense Therapeutics: Receives first approval for phase two DMD clinical trial

FinTech Steve Sam -
Antisense Therapeutics Receives first approval for phase two DMD clinical trial Antisense Therapeutics (ANP) receives approval to conduct its...

Antisense Therapeutics: Shares rise on long COVID-19 study

FinTech Steve Sam -
Antisense Therapeutics Shares rise on long COVID-19 study Antisense Therapeutics (ANP) announces the outcomes of its collaboration to study...

Free News - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.

Company

Headlines

Revolut Introduces Street Mode to Combat Transfer Mugging

0
A new feature aimed at enhancing user safety during...

Deutsche Börse’s $5.5 Billion Bid for Allfunds: Implications for Fintech

0
Exploring Deutsche Börse's strategic acquisition and its impact on...

Nevis Secures $35M to Revolutionize AI in Wealth Management

0
Funding aims to enhance personalized investment strategies through advanced...

South Korea’s NH Nonghyup Bank Tests Blockchain for Cross-Border Payments

0
Exploring innovative solutions in international banking transactions. Highlights: NH Nonghyup...

Newsletter

Get important news delivered directly to your inbox and stay connected!

© Newspaper WordPress Theme by TagDiv